Foppa Caterina, Carrano Francesco Maria, Spinelli Antonino
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy.
Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Milan, Italy.
Clin Colon Rectal Surg. 2022 Feb 28;35(2):146-154. doi: 10.1055/s-0041-1742116. eCollection 2022 Mar.
Transanal surgery has gained in popularity during the latter part of the last decade for both rectal cancer and benign disease. The current role for local excision of early rectal neoplastic lesions has expanded due to better understanding of risk factors for lymph node metastasis and heightened awareness for the long-term sequelae of radical surgery. Transanal resection of the rectum (both for cancer or inflammatory bowel diseases) has now been established as a successful procedure that overcomes some of the limitations of the abdominal approaches. Once the feasibility, safety, and the oncologic results of transanal minimally invasive approaches for patients with rectal cancer have been acknowledged, quality of life and functional outcomes have become increasingly important issues. This article provides an overview of the different techniques currently available for the minimally invasive transanal treatment of rectal lesions, particularly focusing on functional outcomes.
在过去十年后半期,经肛门手术在直肠癌和良性疾病治疗中越来越受欢迎。由于对淋巴结转移风险因素有了更好的理解,以及对根治性手术长期后遗症的认识提高,早期直肠肿瘤性病变局部切除的当前作用得到了扩展。经肛门直肠切除术(用于癌症或炎症性肠病)现已被确立为一种成功的手术方法,克服了腹部手术方法的一些局限性。一旦经肛门微创方法对直肠癌患者的可行性、安全性和肿瘤学结果得到认可,生活质量和功能结果就变得越来越重要。本文概述了目前可用于直肠病变微创经肛门治疗的不同技术,尤其关注功能结果。